Victory Capital Management
BHVN

Victory Capital Management’s Biohaven Pharmaceutical Holding Company Ltd. BHVN Stock Holding History

Victory Capital Management’s Portfolio BHVN Stock Details BHVN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-7,150
Closed -$1.08M – 2795
2022
Q3 		$1.08M Buy
+7,150
New +$1.06M ﹤0.01% 1701
2022
Q2 		– Sell
-2,564
Closed -$229K – 2798
2022
Q1 		$229K Buy
2,564
+155
+6% +$19.3K ﹤0.01% 2380
2021
Q4 		$332K Buy
+2,409
New +$306K ﹤0.01% 2348
2019
Q4 		– Sell
-1,215
Closed -$51K – 3823
2019
Q3 		$51K Buy
+1,215
New +$51.3K ﹤0.01% 2676

Other funds holding BHVN

LIP
Liontrust Investment Partners London, United Kingdom $5.86B AUM 23.75% 1-Year Est. Return
KCM
Knoll Capital Management Miami, Florida $180M AUM 66.11% 1-Year Est. Return
BC
Birchview Capital Burlington, Vermont $176M AUM 95.04% 1-Year Est. Return
BTI
Blue Trust Inc Alpharetta, Georgia $9.54B AUM 19.86% 1-Year Est. Return
FIA
FNY Investment Advisers New York $278M AUM 98.95% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
MSCM
McElhenny Sheffield Capital Management Dallas, Texas $404M AUM 19.8% 1-Year Est. Return

Victory Capital Management's BHVN Position: Q4 2022 in Review

Victory Capital Management sold out of Biohaven Pharmaceutical Holding Company Ltd. (BHVN) in Q4 2022, closing a stake of 7,150 shares — an estimated $1.08M sold.

Victory Capital Management first reported a position in BHVN in Q3 2019 and held it in 4 quarters. The position peaked at $1.08M in Q3 2022. 7 funds tracked by Wall St. Rank hold BHVN as of Q4 2022.

  • Victory Capital Management reported no remaining Biohaven Pharmaceutical Holding Company Ltd. position as of Q4 2022 after selling out during the quarter.
  • Victory Capital Management sold 7,150 Biohaven Pharmaceutical Holding Company Ltd. shares in Q4 2022, an estimated $1.08M.
  • Victory Capital Management first reported a position in Biohaven Pharmaceutical Holding Company Ltd. in Q3 2019 and held it in 4 quarters.
  • Victory Capital Management's Biohaven Pharmaceutical Holding Company Ltd. position peaked at $1.08M in Q3 2022.
  • 7 funds tracked by Wall St. Rank held Biohaven Pharmaceutical Holding Company Ltd. as of Q4 2022.

Based on Victory Capital Management's 13F filing for Q4 2022, filed 9 Feb 2023.